0

Devazepide

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP103420775
CAS103420-77-5
Structure
MDL NumberMFCD00864500
Molecular Weight408.45
InChI KeyNFHRQQKPEBFUJK-HSZRJFAPSA-N
Description≥98% (HPLC), powder
SolubilityDMSO: >5 mg/mL
Assay≥98% (HPLC)
Colorwhite to off-white
Formpowder
Size5MG, 25MG
Storage Conditions2-8°C
1

An Evaluation of the Influence of Devazepide and CCK-8S on the Intact and Resected Rat Liver

B Ohlsson, J F Rehfeld, J Axelson

Eur Surg Res. 1998;30(6):378-84.

PMID: 9838229

1

Cannabinoid CB 1 Receptors Inhibit Gut-Brain Satiation Signaling in Diet-Induced Obesity

Donovan A Argueta, Pedro A Perez, Alexandros Makriyannis, Nicholas V DiPatrizio

Front Physiol. 2019 Jun 11;10:704.

PMID: 31281260

1

Critical Review Evaluating the Pig as a Model for Human Nutritional Physiology

Eugeni Roura, Sietse-Jan Koopmans, Jean-Paul Lallès, Isabelle Le Huerou-Luron, Nadia de Jager, Teun Schuurman, David Val-Laillet

Nutr Res Rev. 2016 Jun;29(1):60-90.

PMID: 27176552

1

Devazepide-induced Hyperplasia in the Rat Liver and Bile Ducts

B Ohlsson, J Axelson, J F Rehfeld, I Ihse

Eur Surg Res. Jul-Aug 1996;28(4):299-305.

PMID: 8813655

1

The cholecystokinin-1 Receptor Antagonist Devazepide Increases Cholesterol Cholelithogenesis in Mice

Helen H Wang, Piero Portincasa, David Q-H Wang

Eur J Clin Invest. 2016 Feb;46(2):158-69.

PMID: 26683129

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode